Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating expenses
Research and development	$ 938,620	$ 1,451,236
General and administrative	1,998,389	2,613,093
Total operating expenses	2,937,009	4,064,329
Operating loss	(2,937,009)	(4,064,329)
Other expense	(10,411)	(8,978)
Loss before income taxes	(2,947,420)	(4,073,307)
Income taxes
Net loss	$ (2,947,420)	$ (4,073,307)
Loss per common share - basic and diluted (in dollars per share)	$ (0.32)	$ (0.62)
Weighted average shares outstanding - basic and diluted (in shares)	9,130,984	6,565,514